← brief for 2026-10-01 · Slowing decline

Nephroprotective Effects of the Dual GCGR/GLP-1R Agonist Survodutide in Hypertension-Accelerated Diabetic Kidney Disease.

Article D Peer reviewed Preclinical

Key takeaways

This study tested a new drug called survodutide in mice with diabetic kidney disease. The drug helped protect the kidneys in these animals. This was a preclinical study, so it has not been tested in people yet.

Who did this work

Hamilton A · Thisted L · Ougaard M · Hahn M · Andersen K · Perens J · Augustin R · Bajrami B · Rist W · Christensen M · Hansen HH · Klein T

Source

Article · PubMed, the drug frontier · 2026 Oct 1
https://pubmed.ncbi.nlm.nih.gov/42823075/